Your browser doesn't support javascript.
loading
Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas.
Looyenga, Brendan D; Furge, Kyle A; Dykema, Karl J; Koeman, Julie; Swiatek, Pamela J; Giordano, Thomas J; West, Andrew B; Resau, James H; Teh, Bin T; MacKeigan, Jeffrey P.
Affiliation
  • Looyenga BD; Laboratory of Systems Biology, Van Andel Research Institute, Grand Rapids, MI 49503, USA.
Proc Natl Acad Sci U S A ; 108(4): 1439-44, 2011 Jan 25.
Article in En | MEDLINE | ID: mdl-21220347
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Protein Serine-Threonine Kinases / Receptors, Growth Factor / Proto-Oncogene Proteins c-met Type of study: Prognostic_studies Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2011 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Signal Transduction / Protein Serine-Threonine Kinases / Receptors, Growth Factor / Proto-Oncogene Proteins c-met Type of study: Prognostic_studies Limits: Humans Language: En Journal: Proc Natl Acad Sci U S A Year: 2011 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos